Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jinxin Fertility Group Ltd. ( (HK:1951) ) has provided an announcement.
Jinxin Fertility Group reported that its IVF treatment volumes continued to recover in the fourth quarter of 2025, with full-year 2025 IVF cycles down just 1.4% from 2024, a marked improvement from the 5.2% decline seen over the first three quarters. The company’s Chengdu flagship hospital turned a 1.9% drop in IVF cycles for the first three quarters into a 1.3% year-on-year increase for the full year, while declines in the Greater Bay Area and overseas markets narrowed significantly, and the group’s Greater China business nearly returned to 2024 levels with only a 0.4% full-year decrease despite a weak first half. Management highlighted ongoing operational optimization and outlined plans for 2026 and beyond, including enhancing clinical efficacy, upgrading reproductive technologies, accelerating the ramp-up and market penetration of its relocated Greater Bay Area hospital, and leveraging supportive fertility policies in China to strengthen its competitive position and drive long-term growth for shareholders and the broader reproductive health sector.
The most recent analyst rating on (HK:1951) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page.
More about Jinxin Fertility Group Ltd.
Jinxin Fertility Group Limited, incorporated in the Cayman Islands and listed in Hong Kong, operates a network of fertility hospitals and clinics, focusing on in vitro fertilization (IVF) and reproductive health services. Its core markets are Greater China, including flagship operations in Chengdu, the Greater Bay Area, Kunming and Wuhan, and selected overseas locations such as the United States, with past operations in Laos now terminated.
Average Trading Volume: 20,730,658
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.59B
Find detailed analytics on 1951 stock on TipRanks’ Stock Analysis page.